Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.21−0.07 (-5.47%)
Close on Nov 13, 2026Market cap $10.90MP/E –Yield –
Lisata Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Lisata Therapeutics's profit margin for the twelve months ending Sep 30, 2026 was -17159.0%. For fiscal 2025 it was -9756.5%, against -1998.5% the year before. The highest annual figure on record is -33.4% in fiscal 2010.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9756.5% | −7758.0 |
| FY2024 | Dec 31, 2024 | -1998.5% | −1905.9 |
| FY2016 | Dec 31, 2016 | -92.6% | +213.3 |
| FY2014 | Dec 31, 2014 | -305.9% | −40.1 |
| FY2013 | Dec 31, 2013 | -265.7% | +109.5 |
| FY2012 | Dec 31, 2012 | -375.2% | +93.8 |
| FY2011 | Dec 31, 2011 | -469.0% | −435.6 |
| FY2010 | Dec 31, 2010 | -33.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -2954.0% | – |
| Q2 FY2025 | Jun 30, 2025 | -6655.7% | – |
| Q4 FY2024 | Dec 31, 2024 | -461.0% | – |
See a number that looks wrong?